Home » Topics » BioWorld Science

BioWorld Science
RSS

Machine learning approach speeds resistance identification

Jan. 17, 2022

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Jan. 17, 2022

Study brings clarity on how MS starts, although not yet why

Jan. 14, 2022

[225Ac]OTSA-101 confers complete remission in preclinical model of synovial sarcoma

Jan. 14, 2022

HGF mimetic CM-1021 stimulates liver growth in mice

Jan. 14, 2022

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Gilead Sciences synthesizes new HIV antivirals

Jan. 14, 2022

X4 Pharmaceuticals presents new CXCR4 antagonists

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...